Table 3.

Associations between baseline cTnI concentrations and outcomes.

OutcomeHR (95% CI)
Model 1aModel 2Model 3Model 4
Cardiovascular death
    Both sexes1.93 (1.85–2.01)1.31 (1.23–1.40)1.27 (1.19–1.35)1.23 (1.15–1.31)
    Women2.13 (2.02–2.25)1.51 (1.38–1.65)1.49 (1.36–1.64)1.44 (1.31–1.58)
    Men1.73 (1.62–1.84)1.18 (1.08–1.29)1.14 (1.04–1.25)1.10 (1.00–1.20)
All-cause mortality
    Both sexes1.80 (1.74–1.85)1.21 (1.28–1.45)1.19 (1.14–1.25)1.17 (1.12–1.22)
    Women1.96 (1.88–2.03)1.36 (1.28–1.45)1.36 (1.27–1.46)1.33 (1.24–1.42)
    Men1.64 (1.57–1–72)1.11 (1.04–1.17)1.10 (1.03–1.17)1.08 (1.01–1.15)
  • a Model 1, unadjusted; model 2, adjusted for sex and age; model 3, adjusted for sex, age, total and HDL cholesterol, systolic blood pressure, treatment of hypertension, smoking status, and diabetes status; model 4, adjusted for sex, age, total and HDL cholesterol, systolic blood pressure, treatment of hypertension, smoking status, diabetes status, estimated glomerular filtration rate, history of myocardial infarction, and C-reactive protein.